6wiv
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
<StructureSection load='6wiv' size='340' side='right'caption='[[6wiv]], [[Resolution|resolution]] 3.30Å' scene=''> | <StructureSection load='6wiv' size='340' side='right'caption='[[6wiv]], [[Resolution|resolution]] 3.30Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6WIV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6WIV FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=U3D:[(2R)-3-[(Z)-icos-11-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl]+2-(trimethylazaniumyl)ethyl+phosphate'>U3D</scene>, <scene name='pdbligand=U3G:(2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl+(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate'>U3G</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.3Å</td></tr> |
- | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CLR:CHOLESTEROL'>CLR</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=U3D:[(2R)-3-[(Z)-icos-11-enoyl]oxy-2-[(Z)-octadec-9-enoyl]oxypropyl]+2-(trimethylazaniumyl)ethyl+phosphate'>U3D</scene>, <scene name='pdbligand=U3G:(2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-{[(9Z)-octadec-9-enoyl]oxy}propyl+(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoate'>U3G</scene></td></tr> | |
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6wiv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6wiv OCA], [https://pdbe.org/6wiv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6wiv RCSB], [https://www.ebi.ac.uk/pdbsum/6wiv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6wiv ProSAT]</span></td></tr> |
</table> | </table> | ||
- | == Function == | ||
- | [[http://www.uniprot.org/uniprot/GABR1_HUMAN GABR1_HUMAN]] Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis. Calcium is required for high affinity binding to GABA. Plays a critical role in the fine-tuning of inhibitory synaptic transmission. Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials. Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception. Activated by (-)-baclofen, cgp27492 and blocked by phaclofen.<ref>PMID:9844003</ref> <ref>PMID:9872316</ref> <ref>PMID:18165688</ref> <ref>PMID:22660477</ref> Isoform 1E may regulate the formation of functional GABBR1/GABBR2 heterodimers by competing for GABBR2 binding. This could explain the observation that certain small molecule ligands exhibit differential affinity for central versus peripheral sites.<ref>PMID:9844003</ref> <ref>PMID:9872316</ref> <ref>PMID:18165688</ref> <ref>PMID:22660477</ref> [[http://www.uniprot.org/uniprot/GABR2_HUMAN GABR2_HUMAN]] Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2. Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis. Plays a critical role in the fine-tuning of inhibitory synaptic transmission. Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials. Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception.<ref>PMID:9872316</ref> <ref>PMID:10328880</ref> <ref>PMID:18165688</ref> <ref>PMID:22660477</ref> | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 26: | Line 24: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
- | [[Category: Human]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Cao | + | [[Category: Cao B]] |
- | [[Category: Chen | + | [[Category: Chen S]] |
- | [[Category: Clarke | + | [[Category: Clarke OB]] |
- | [[Category: Eng | + | [[Category: Eng ET]] |
- | [[Category: Fan | + | [[Category: Fan QR]] |
- | [[Category: Fiehn | + | [[Category: Fiehn O]] |
- | [[Category: Frangaj | + | [[Category: Frangaj A]] |
- | [[Category: Frank | + | [[Category: Frank J]] |
- | [[Category: Fu | + | [[Category: Fu Z]] |
- | [[Category: Geng | + | [[Category: Geng Y]] |
- | [[Category: Grassucci | + | [[Category: Grassucci R]] |
- | [[Category: Graziano | + | [[Category: Graziano J]] |
- | [[Category: Hendrickson | + | [[Category: Hendrickson WA]] |
- | [[Category: Huang | + | [[Category: Huang RK]] |
- | [[Category: Javitch | + | [[Category: Javitch JA]] |
- | [[Category: Kloss | + | [[Category: Kloss B]] |
- | [[Category: Kou | + | [[Category: Kou Y]] |
- | [[Category: Lin | + | [[Category: Lin X]] |
- | [[Category: Liu | + | [[Category: Liu J]] |
- | [[Category: Liu | + | [[Category: Liu Z]] |
- | [[Category: Mosyak | + | [[Category: Mosyak L]] |
- | [[Category: Park | + | [[Category: Park J]] |
- | [[Category: Quick | + | [[Category: Quick M]] |
- | [[Category: Ray | + | [[Category: Ray KM]] |
- | [[Category: Rice | + | [[Category: Rice WJ]] |
- | [[Category: Shen | + | [[Category: Shen T]] |
- | [[Category: Slavkovich | + | [[Category: Slavkovich VN]] |
- | [[Category: Slesinger | + | [[Category: Slesinger PA]] |
- | [[Category: Soni | + | [[Category: Soni RK]] |
- | [[Category: Taura | + | [[Category: Taura J]] |
- | [[Category: Williams | + | [[Category: Williams JP]] |
- | [[Category: Yu | + | [[Category: Yu H]] |
- | [[Category: Yu | + | [[Category: Yu Z]] |
- | [[Category: Zuo | + | [[Category: Zuo H]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Current revision
Structure of human GABA(B) receptor in an inactive state
|
Categories: Large Structures | Cao B | Chen S | Clarke OB | Eng ET | Fan QR | Fiehn O | Frangaj A | Frank J | Fu Z | Geng Y | Grassucci R | Graziano J | Hendrickson WA | Huang RK | Javitch JA | Kloss B | Kou Y | Lin X | Liu J | Liu Z | Mosyak L | Park J | Quick M | Ray KM | Rice WJ | Shen T | Slavkovich VN | Slesinger PA | Soni RK | Taura J | Williams JP | Yu H | Yu Z | Zuo H